Copyright
©The Author(s) 2020.
World J Clin Cases. Jul 6, 2020; 8(13): 2876-2884
Published online Jul 6, 2020. doi: 10.12998/wjcc.v8.i13.2876
Published online Jul 6, 2020. doi: 10.12998/wjcc.v8.i13.2876
Figure 1 Imaging examinations.
A: Primary cancer in the apical segment of the upper lobe of the right lung before surgery in the lung window (yellow arrow); B: Primary cancer in the apical segment of the upper lobe of the right lung before surgery in the mediastinal window (orange arrow); C: No bone metastasis existed before surgery at baseline; D: right lung metastasis 1 mo after surgery (orange arrow); E: left lung metastasis 1 mo after surgery (orange arrow); F: Bone metastases 1 mo after surgery (orange arrow); G: Adrenal gland metastases 1 mo after surgery (orange arrow).
- Citation: Chen P, Yu M, Zhang JL, Chen WY, Zhu L, Song Y, Jiang CY, Zhang S. Significant benefits of pembrolizumab in treating refractory advanced pulmonary sarcomatoid carcinoma: A case report. World J Clin Cases 2020; 8(13): 2876-2884
- URL: https://www.wjgnet.com/2307-8960/full/v8/i13/2876.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i13.2876